NICHD -- Male and Female Contraceptive Development (R43/R44 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved contraceptive products for men and women.


  • Letter of Intent Due Date(s):30 days prior to the application due date
  • Application Due Date(s): April 16, 2018

RFA-HD-19-004  Expiration Date April 17, 2018

Agency Website

Eligibility Requirements

Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Amount Description

Budgets up to $225,000 total costs per year for Phase I and up to $1,500,000 total costs per year for Phase II may be requested.

Funding Type





Engineering and Physical Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

April 16, 2018